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Summary 
Transient receptor potential (TRP) cation channels are emerging in vascular biology. In 
particular, expression of the capsaicin receptor (TRPV1) was reported in vascular smooth 
muscle cells. This arteriolar TRPV1 function and expression was characterized here in 
the rat. 
TRPV1 mRNA expressed in various vascular beds. Six commercially available 
antibodies were tested for TRPV1 specificity. Two of them was specific (immunostaining 
was abolished by blocking peptides) for neuronal TRPV1 and one of these antibodies 
recognized vascular TRPV1. TRPV1 was expressed in blood vessels in the skeletal 
muscle, mesenteric and skin tissues, besides to the aorta and carotid arteries. TRPV1 
expression was found to be regulated at the level of individual blood vessels (some 
vessels expressed, while others did not express TRPV1 in the same tissue sections). 
Capsaicin (a TRPV1 agonist) evoked constrictions in skeletal muscle arteries and in the 
carotid artery, while it did not have effects in femoral and mesenteric arteries and in the 
aorta. 
TRPV1 expression in blood vessels was detected in most large arteries, but there 
are striking differences at level of the small arteries. TRPV1 activity was suppressed in 
some isolated arteries. This tightly regulated expression and function suggests a 
physiological role for the vascular TRPV1. 
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Introduction 
Capsaicin is the most irritative component in hot chilli peppers (Szallasi and Blumberg 
1999). The receptor which mediates the hot painful feeling upon capsaicin exposure 
(transient receptor potential channel vanilloid 1, TRPV1) was cloned and identified in 
sensory neurons (Tominaga et al. 1998). The physiological effects of capsaicin identified 
TRPV1 as a promising therapeutic target to modulate pain perception and an extensive 
pharmaceutical effort was made to develop TRPV1 antagonists to relieve pain (Szallasi 
and Blumberg 1999). There are hundreds of patents and thousands of molecules 
developed to modulate TRPV1. However, this effort did not result in a breakthrough in 
pain treatment, which is related to the physiological effects of the developed TRPV1 
antagonists. In appears that TRPV1 involved in body temperature maintenance besides 
other functions, giving rise of on-target side effects (Gavva 2008; Holzer 2008; Szallasi 
and Sheta 2012). 
 TRPV1 expression has been identified in various tissues in addition to sensory 
neurons. In particular, TRPV1 was found in the central nervous system (Toth et al. 2005) 
and in the peripheral blood vessels (Lizanecz et al. 2006). Later research on the effects of 
TRPV1 stimulation on the blood vessels suggested both dilation and constriction upon 
TRPV1 stimulation (Kark et al. 2008). TRPV1 mediated dilations were related to the 
perivascular sensory neuronal terminals, which may release neurotransmitters (CGRP, 
substance P) upon stimulation, mediating vasodilation (Zygmunt et al. 1999). The 
vasoconstrictive TRPV1 was much less characterised. Nonetheless, we  (Czikora et al. 
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2012; Kark et al. 2008) and others (Cavanaugh et al. 2011) have recently proven that 
functional TRPV1 is expressed in arteriolar smooth muscle cells, where its activation 
result is an increase in intracellular Ca2+ concentration and vasoconstriction.  
 Transient receptor potential vanilloid (TRPV1-6) channels are gaining an 
attention in vascular biology. They are cation channels, with some selectivity to Ca2+ 
(Baylie and Brayden 2011). However, there is little consistency in the reports regarding 
the role of TRPV1 in vascular biology. In particular, some of the reports suggest that the 
same arteries can respond to capsaicin by dilation and also by constriction depending on 
the conditions (Baylie and Brayden 2011). The opposite effects of capsaicin on vascular 
diameter was explained by its localisation in sensory neuronal terminals (mediating 
dilation) and in vascular smooth muscle cells (Kark et al. 2008).  
 We performed a detailed study here to reveal functional TRPV1 expression in 
various vascular tissue of the rat. First, specific antibodies were identified for the sensory 
neuronal TRPV1 and then vascular TRPV1 expression was studied in detail. These data 
revealed that TRPV1 expression in the vascular beds are not uniform. Some of the 
vessels in the same tissue section express TRPV1 while other vessels are apparently 
without TRPV1 expression. Moreover, TRPV1 responses to capsaicin are greatly 
different in isolated arteries where TRPV1 appears to be highly expressed, suggesting a 
tight regulation of TRPV1 sensitivity in arteriolar smooth muscle. 
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Methods 
 
Animals, anaesthesia and general preparation in the in vivo experiments 
Male Wistar Kyoto (WKY/NCrl) rats (Charles River, Isaszeg, Hungary) were fed ad 
libitum (chow from Szinbad Kft, Godollo, Hungary). Rats were 250-450 g when 
experiments were started. Anaesthesia was done by 50 mg/kg i.p. thiopental. Animal 
experiments were carried out at and approved by the University of Debrecen, Medical 
and Health Science Center, and were in accordance with the standards established by the 
National Institutes of Health. 
 
Total RNA preparation, reverse transcription and RT-qPCR 
Tissue samples were prepared as described later for cannulated arteries. Reverse 
transcription coupled quantitative PCR was performed as described in (Bai et al. 2007). 
Briefly, total RNA was prepared using Trizol reagent (Life Technologies, Budapest, 
Hungary) according to the manufacturer’s instructions. RNA was treated with DNase and 
0.5 μg RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems, Foster City, CA, USA). cDNA was purified on Qiaquick PCR 
cleanup columns (Qiagen, Valencia, CA, USA). 10-fold diluted cDNA was used for 
qPCR reactions. The quantitative PCR reactions were preformed using a LightCycler 480 
system (Roche, Basel, Switzerland) and a qPCR supermix (Biocenter, Szeged, Hungary) 
with the following primers: TRPV1 (fwd: 5’-gaatgacaccatcgctctgc; rev: 5’- 
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aagagggtcaccagcgtcat) and 36B4 as control (fwd: 5’- ccccgtgtgaggtcacagta; rev: 5’- 
atgatcagcccgaaggagaa). TRPV1 expression was normalized for 36B4 expression. Finally, 
the products of the PCR amplification were run on a 2% agarose gel to verify their size. 
To check for the amplification of primer dimers the template was omitted from the 
controls and melting curve analysis was performed. 
 
 
Immunohistochemistry 
Tissue samples (dorsal root ganglia, gracilis muscle, mesenterium, femoral muscle, aorta, 
carotid artery and the ears) were dissected from the rat and embedded in Tissue-Tek 
O.C.T compound (Electron Microscopy Sciences, Hatfield, PA, USA). Cryostat sections 
(thickness 10 μm) were made. Sections were fixed in acetone for 10 min and blocked 
with normal goat sera (1.5 % in PBS, Sigma, St. Louis, MO, USA, 20 min). TRPV1 was 
stained by anti-capsaicin receptor antibodies. Antibodies were obtained from Alomone 
(anti-TRPV1-C, 3rd loop) Calbiochem (anti-TRPV1-N), Osenses (3rd loop, 4th loop) and 
Neuromics (N-terminal). Details of the source and dilution of the antibodies are shown in 
Table 1. Blocking peptides (synthesized based on the immunogenic TRPV1 fragment 
used to develop the antibodies) were also used in some cases. Binding of the TRPV1 
specific antibodies was visualized by fluorescent secondary antibodies (Table 1) by a 
Zeiss Meta confocal microscope (Zeiss, Oberkochen, Germany). Tissue sections were 
also co-stained with an anti-smooth muscle actin (Table 1) or with a neurofilament-
Copyright © 2013 The Author(s) 
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specific antibody (Table 1) in the blocking buffer.  Pictures were processed by ImageJ 
software (freeware from www.nih.gov) to calculate cross sectional areas. Cross sectional 
areas were calculated by applying the AUTO mode for the dorsal root ganglia pictures in 
both the Threshold and the Particle analysis menu (the single manual adjustment was to 
set the maximum area to 1000).  
 
Western blot 
Tissue samples (dorsal root ganglia and carotid artery) were dissected from the rat. Tissue 
samples (about 20 ganglia and the two carotid arteries) were pooled, and homogenized in 
200 µl of SDS sample buffer (S3401, Sigma, St. Louis, MO, USA) and homogenized by 
a glass tissue homogenizer. Cultured human embryonic kidney cells (HEK293, LGC 
standards, Wesel, Germany) were transfected by a human TRPV1-expression plasmid 
(pdEYFP-C1 construct, RZPD, Berlin, Germany). HEK293 cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated 
FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (all from Life 
Technologies, Budapest, Hungary) at 37°C, 5% CO2. HEK293 cells (control and 
transfected) were collected from 100 mm diameter Petri Dishes and homogenized in 500 
µl of SDS sample buffer. All homogenized samples were incubated at 100°C for 10 min. 
Protein concentration was determined using a BSA standard. 30 µg of protein was loaded 
onto 10% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. The 
membranes were then stained by a reversible protein staining dye (Ponceau S) and were 
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cut into strips each containing the above mentioned samples and a prestained molecular 
weight standard (ProSieve QuadColor, Lonza, Rockland, Maine, USA) and probed by 
TRPV1 specific antibodies (Table 1). Blocking peptides (Table 1) were obtained from 
Alomone, (Jerusalem, Israel, ACC-030 antibody) and from EZBiolab (Caramel, IN, 
USA, PC547 antibody). Blocking peptides were used in a ratio of 1 µg peptide : 1 µg 
antibody and were preincubated with their respective antibodies for 60 min at room 
temperature. All primary antibodies (Table 1) were suggested to work in Western blotting 
by the company data sheets. The dilutions suggested by the manufacturers were used here 
(Table 1). Binding of the primary antibodies were detected by an anti-rabbit-POD 
secondary antibody (Sigma, St. Louis, MO, USA). Peroxidase reaction was detected by 
ECL (Western lighting plus ECL, PerkinElmer, Waltham, MA, USA) and the signal was 
recorded by an imaging system (MF-Chemibis 3.2, Central European Biosystems, 
Budapest, Hungary). All of the membranes showed on Fig. 5 were developed together, 
exposition time was 6 min. Intensity range on the pictures shown on Fig. 5 is 0-15984 
(recording was done in the range of 0-65535). 
 
Preparation of cannulated arterioles 
Isolation of the skeletal (gracilis) muscle arterioles of the rat and diameter measurement 
of the arterioles were performed as described earlier (Lizanecz et al. 2006). Preparation 
of small mesenteric resistance arteries were performed likewise. The internal diameter of 
the arterioles were measured by video microscopy. Experiments were carried out in PSS 
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(composition in mM: 110 NaCl, 5.0 KCl, 2.5 CaCl2, 1.0 MgSO4, 1.0 KH2PO4, 5.0 
glucose and 24.0 NaHCO3 equilibrated with a gas mixture of 10% O2 and 5% CO2, 85% 
N2, at pH 7.4). After the development of spontaneous myogenic tone at 80 mmHg 
arteriolar responses to acetylcholine (edothel dependent dilation, 1 nM-10 µM), to 
norepinephrine (vasoconstrictor, 1 nM-10 µM) and to capsaicin (TRPV1 agonist, 1 nM-
10 µM) were measured.  Agonists were applied in a cumulative fashion.  
 
Measurement of arteriolar contractions under isometric conditions 
Large arteries were prepared from the rat in Ca2+ free PSS. 4 mm long segments of the 
vessels were fixed on a contractile force measurement setup (DMT510A, Danish 
Myotechnology, Aarhus, Denmark). After fixing of the vessels on the setup in Ca2+-free 
PSS, the buffer was changed to PSS and vessels were stretched by 10 mN. Mounted 
arteries were incubated in PSS for 40-60 min (until force values were stabilized) at 37oC. 
Experiments were started by the addition of the smooth muscle dependent 
vasoconstrictive agent norepinephrine or U-46619 in a cumulative fashion (1 nM-10 
μM). After reaching the maximal response, these agents were washed away and the 
vessels were incubated in PSS alone, until the contractile force decreased to the level 
before the application of the vasoconstrictive agents. Finally, capsaicin was applied (1 
nM-30 μM) to investigate TRPV1 mediated vascular effects. 
 
Materials and solutions 
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Chemicals were from Sigma-Aldrich (St. Louis, MO, USA) if not stated otherwise. 
Capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide) was dissolved in ethanol. 
Norepinephrine and acetylcholine were dissolved in distilled water.  
 
Data analysis and statistical procedures 
Arteriolar diameter was determined by measuring the distance between the intraluminal 
sides of the  
arteriolar wall (inner diameter). Data are shown as average diameter ± S.E.M. Statistical 
analysis was made by Microsoft Excel using Student’s t-tests. P-values <0.05 were 
considered to be significant. 
Copyright © 2013 The Author(s) 
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Results 
Non-neuronal expression of TRPV1 
The expression of TRPV1 in vascular tissues were tested by RT-PCR (Fig. 1A) and Q-
PCR (Fig. 1B) in isolated vascular preparations. TRPV1 expression was found to be the 
highest in dorsal root ganglia. Nonetheless, TRPV1 was also expressed in other tissues, 
albeit its expression was two orders of magnitude lower than that of in dorsal root 
ganglia. TRPV1 mRNA expression was not detected in the isolated mesenteric artery 
(values were similar to those performed without template).  
 
Characterization of antibodies developed against TRPV1 
A set of 6 antibodies developed against TRPV1 (Table 1) were tested on dorsal root 
ganglia of the rat. Two antibodies (anti-TRPV1-N and anti-TRPV1-C) stained 
specifically a subset of the neurons within the dorsal root among the six tested, while 
three antibodies (Alomone 3rd loop, Osenses 3rd loop and Osenses 4th loop) did not give 
any cell specific staining pattern and the Neuromics N-terminal antibody had a rather 
nonspecific neuron staining pattern under these conditions (Fig. 2).  The anti-TRPV1-N 
and anti-TRPV1-C antibodies were tested in detail. Both the anti-TRPV1-N (Fig. 3A) and 
anti-TRPV1-C (Fig 3B) antibodies stained (red color on the figure) a subset of cell bodies 
within the dorsal root ganglia of the rat. TRPV1 positive cells were also stained by a 
neurofilament specific antibody, although the intensity of the signal  (green color on Fig. 
3) was weaker in the case of TRPV1 expressing cells than that for the cells which did not 
Copyright © 2013 The Author(s) 
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show TRPV1 positivity. Images recorded at higher magnification in separate experiments 
confirmed this observation (Fig. 4A and Fig. 4C). TRPV1 specific immunostaining 
disappeared when the anti-TRPV1 antibodies were pre-absorbed with their respective 
blocking peptides (anti-TRPV1-N, Fig. 4B, anti-TRPV1-C, Fig. 4D). The company data 
sheets for the TRPV1 antibodies tested in immunohistochemistry (Fig. 2, Table 1) state 
that they are suitable for Western blotting. Antibodies were therefore tested in Western 
blot on dorsal root ganglia, carotid artery, HEK293 and TRPV1-overexpressing HEK293 
cell homogenates (Fig. 5). Some of the antibodies (Alomone 3rd loop, Osenses 4th loop 
and Neuromics N-terminal, Fig. 5A-5C)  gave only nonspecific signals (Fig. 5). The anti-
TRPV1-N antibody did not give any signal under these conditions (Fig. 5E) over the 
background (Fig. 5D). Nonetheless, the anti-TRPV1-C antibody (Fig. 5F) was found to 
be applicable in Western blotting. In particular, it detected TRPV1 in dorsal root ganglia 
and in TRPV1-overexpressing HEK293 cells (but not in untransfected HEK293 cells). 
Moreover, this TRPV1 specific signal disappeared in the presence of the blocking 
peptide.   
 
Characterization of TRPV1 positive structures in the dorsal root ganglia 
The anti-TRPV1-N and anti-TRPV1-C antibodies were used to investigate TRPV1 
expression in the rat. The cross sectional area of the TRPV1 positive neurons was 
measured in the dorsal root ganglia (anti-TRPV1-N, Fig. 6A and anti-TRPV1-C, Fig. 
6B). Both antibodies stained the small diameter neurons (Fig. 6E and 6F, respectively, 
Copyright © 2013 The Author(s) 
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cross sectional diameter was 200-600 μm2), which was in accordance with the size of the 
sensory neurons. Surprisingly, the anti-TRPV1-N antibody also gave a TRPV1-like 
immunoreactivity in vascular beds within (Fig. 6A) or around (Fig. 3A) of the dorsal root 
ganglia. To this end colocalization of TRPV1 with smooth muscle actin was tested. The 
anti-TRPV1-N antibody stained some, but not all smooth muscle cells (Fig. 6B). It 
appeared that some vessels express TRPV1, while other vessels are not in the same tissue 
section. The anti-TRPV1-C antibody did not stain smooth muscle cells (Fig. 6D). 
Functional expression of TRPV1 in the sensory neurons is well established, but its 
expression in the vasculature is a relatively novel concept. The goal of the present study 
was to investigate this vascular TRPV1 by a combination of immunohistochemistry and 
functional measurements. 
  
Characterization of functional TRPV1 expression in different vascular tissues of the rat 
Vascular smooth muscle cells of blood vessels within the gracilis muscle of the rat were 
positively stained by an anti-TRPV1-N antibody (Fig. 7B), while the anti-TRPV1-C 
antibody did not produce a specific staining pattern (Fig. 7D). None of these antibodies 
stained neurites in this tissue (Fig. 7A and 7C, respectively). The TRPV1 positive (anti-
TRPV1-N antibody) arteries were isolated and the effects of a TRPV1 agonist capsaicin 
was tested. Capsaicin evoked a robust constriction in these arterioles, which was 
comparable to that evoked by norepinephrine (Fig. 7E). 
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 These conflicting staining patterns of vascular tissue by the two TRPV1 
antibodies were further investigated by the application of the blocking peptides. The 
smooth muscle staining by the anti-TRPV1-N antibody (Fig. 8A) was blocked by the 
immunogenic TRPV1 fragment (Fig. 8B), confirming the TRPV1 specificity of the 
staining. On the other hand, there was no signal above the background in the case of the 
anti-TRPV1-C antibody (Fig. 8C and 8D). 
 An inhomogeneous staining pattern was found in the mesenteric tissue with the 
anti-TRPV1-N antibody (Fig. 9A and 9B), while the anti-TRPV1-C antibody (Fig. 9C 
and 9D) was again without specific staining. Some of the blood vessels were positive for 
TRPV1, while some other vessels were not stained in the same tissue section (Fig. 9A 
and 9B). Capsaicin was without functional effects, although norepinephrine evoked 
substantial vasoconstrictions (Fig. 9E). 
 The anti-TRPV1-N antibody gave a strong positive staining in case of the femoral 
artery (Fig. 10B), while the anti-TRPV1-C antibody showed a weak background staining 
in the skeletal muscle cells (Fig. 10D). Capsaicin was without effects in the functional 
measurements on these (isolated) arteries, compared to the constrictions evoked by 
norepinephrine (Fig. 10E). None of the peripheral neurites were stained by these 
antibodies (Fig. 10A and 10C). 
 The next vascular tissue to be studied was the aorta. The aorta was positively 
stained for TRPV1 by the anti-TRPV1-N antibody (Fig. 11B), but not with the anti-
TRPV1-C antibody (Fig. 11D). Capsaicin was without effects on the isolated rings, while 
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norepinephrine evoked substantial constrictions (Fig. 11E). There was no neuronal 
staining in these tissue sections (Fig. 11A and 11C). 
Carotid artery was also tested. Again, the anti-TRPV1-N antibody stained the smooth 
muscle layer of the tissue (Fig. 12B), while the anti-TRPV1-C antibody was without 
specific staining (Fig. 12D). Nonetheless, capsaicin evoked a partial constriction in 
carotid arteries, which was about 20% of the maximal constriction, achieved by the 
thromboxane A2 agonist U-46619 (Fig. 12E). Besides to the vessels, no neuron specific 
staining was found (Fig. 12A and 12C). 
 Finally, a tissue important in the thermoregulation was tested. Staining of the ears 
of the rat revealed that both the anti-TRPV1-N and anti-TRPV1-C antibodies can stain 
peripheral axons (Fig. 13A and 13C, respectively). The anti-TRPV1-C antibody did not 
stain specifically other structures (Fig. 13D). In contrast, the anti-TRPV1-N antibody 
again stained some of the blood vessels (Fig. 13B). It is important to note, that a very 
limited number of blood vessels were stained, and they appeared to have a larger 
diameter (Fig. 13B). 
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Discussion 
There are numerous reports about TRPV1 expression in non-neuronal tissues. Here we 
made an effort to characterize these TRPV1 populations in the peripheral tissues of the 
rat. The presence of TRPV1 mRNA was established first. Q-PCR data (Fig. 1B) 
suggested, that TRPV1 is indeed expressed in vascular preparations, although the 
expression level was about two orders of magnitude lower than that is in dorsal root 
ganglia. 
 After establishing the presence of TRPV1 in vascular tissues an effort was made 
to identify antibodies suitable for the detection of TRPV1 expression. An extensive 
testing of six commercially available antibodies was performed. It was found that only 
two of the 6 tested antibodies stained TRPV1 selectively in the dorsal root ganglia of the 
rat. These antibodies (referred as anti-TRPV1-N and anti-TRPV1-C) were then 
characterized in detail. It was found that one of the antibodies tested (anti-TRPV1-C) 
detects endogenous (dorsal root ganglia) and exogenous (transfected HEK293 cells) 
TRPV1 in Western blotting, which can be blocked by the antigenic peptide. Moreover, 
TRPV1 staining of sensory neurons (anti-TRPV1-N and anti-TRPV1-C antibodies) and 
vascular smooth muscle cells (anti-TRPV1-N antibody) was blocked by the antigenic 
peptides, suggesting that these antibodies are specific for TRPV1. 
 We have concentrated our efforts to the blood vessels and the staining was 
performed in parallel with functional measurements on the same arteries, when it was 
possible. First, the gracilis muscle was tested, because in the case of skeletal muscle 
Copyright © 2013 The Author(s) 
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arteries we have previously provided a convincing set of data suggesting functional 
TRPV1 expression (Czikora et al. 2012; Kark et al. 2008; Lizanecz et al. 2006). Indeed, 
TRPV1 was found to be abundantly expressed in all blood vessels within the gracilis 
muscle by the anti-TRPV1-N antibody. Interestingly, the anti-TRPV1-C antibody did not 
give any positive staining in the case of this tissue suggesting that the anti-TRPV1-C 
antibody does not recognize the vascular smooth muscle located TRPV1, while it is 
suitable for the detection of TRPV1 in sensory neurons by Western blot and 
immunohistochemistry. One may argue, that the vascular smooth muscle staining 
observed by the anti-TRPV1-N antibody is an artifact, but there are many reasons making 
this hypothesis unlikely. In particular, (1) vascular TRPV1 staining was blocked by the 
TRPV1 specific antigenic peptide (Fig. 8); (2) the vascular TRPV1 expression is in 
accordance with the constrictive effect of the TRPV1 agonist capsaicin. Capsaicin 
mediated vasoconstriction is missing in TRPV1-/- mice (Czikora et al. 2012), strongly 
suggesting that capsaicin response is specific for TRPV1; (3) TRPV1 mRNA is present in 
the isolated arteriolar preparations (Fig. 1); (5) earlier reports by an independent group 
also showed functional arteriolar TRPV1 expression (Cavanaugh et al. 2011). 
 The goal of the present work was to study TRPV1 expression and function in a set 
of rat tissue samples and on isolated arteries, using the anti-TRPV1-C antibody as a 
TRPV1 expression marker in the vascular tissue. There were several important 
observations. First, it turned out, that the TRPV1 is not uniformly expressed in the 
vascular tissues. It was found that TRPV1 only expressed in a subset of blood vessels in 
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some tissues (in particular mesenteric, and skin tissues). The observed differences in 
TRPV1 stainings (in the same tissue sections) suggests a complex regulation of TRPV1 
expression at the level of the individual vessels. 
 Another surprising observation was that the functional responses of the TRPV1 
positive (anti-TRPV1-N antibody) arteries were in a wide range. While arteries from the 
gracilis muscle responded to capsaicin by a robust constriction, which was comparable to 
that of evoked by norepinephrine (representing the maximal physiological 
vasoconstriction in this particular case), other arteries (e.g. carotid artery) had a limited 
functional TRPV1 response even if an apparently high level of TRPV1 expression was 
found. Moreover, some of the arteries expressing TRPV1 did not contracted upon 
capsaicin application (femoral and mesenteric arteries, aorta). 
 These apparent controversies between TRPV1 function and expression may be 
explained by many factors. First, it is possible that TRPV1 expression is regulated at the 
cellular level. One of the observations, supporting this hypothesis is that only a portion of 
isolated coronary smooth muscle cells responded to capsaicin by increasing intracellular 
Ca2+ concentrations (Czikora et al. 2012). Another possibility is that TRPV1 expression 
is regulated at the level of the individual blood vessels (Cavanaugh et al. 2011). It is 
supported by the staining patterns here, showing that the smooth muscle layer is 
uniformly stained in a given blood vessel, although some of the blood vessels are stained 
while others are not in the same tissue slice. It needs to be mentioned, that this vessel 
specific staining pattern has also been reported earlier with a genetically engineered mice 
Copyright © 2013 The Author(s) 
 
 at University of Debrecen on November 14, 2013jhc.sagepub.comDownloaded from 
JHC Express 
Accepted September 30, 2013 
This article can be cited as DOI: 10.1369/0022155413513589 
 
 
 
 
20 

(genetical labelling of TRPV1 by a fluorescent protein), although the same group was not 
able to stain unmodified TRPV1 in the same localization (Cavanaugh et al. 2011). 
Finally, it is also possible that activity of vascular TRPV1 is also controlled by 
posttranslational modifications. In this case the physiological activity of vascular TRPV1 
may be regulated by sensitization-desensitization of the receptor. As a matter of fact, it 
was found that vascular TRPV1 can be desensitized, which process involved the 
activation of the Ca2+ dependent phosphatase, calcineurin (Lizanecz et al. 2006).  
 An alternative explanation for the differences in the arteriolar response to 
capsaicin in case of gracilis, femoral, carotid arteries and aorta may be the existence of 
different TRPV1 isoforms. All the preparations gave strong staining with the anti-
TRPV1-N antibody. Nonetheless, at least three different TRPV1 splicing variants have 
been suggested, which has low sensitivity for agonists (such as the capsaicin used here) 
(Eilers et al. 2007; Tian et al. 2006; Vos et al. 2006; Wang et al. 2004). Moreover, these 
splice variants may associate with the dominant (functional) form of the TRPV1, and 
inhibit its activity (without affecting its apparent expression when tested by 
immunohistochemistry). Here we performed a morphological study, in which we found 
striking differences in the TRPV1 staining pattern within arteries in close proximity (on 
the same tissue section) and showed that large arteries with apparently similar TRPV1 
expression have strikingly different capsaicin sensitivity. It requires further studies to 
identify the reasons of these differences. Regardless of the complicated regulation, 
the main question is the functional role of TRPV1 in vascular biology. TRPV1 mediated 
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vasoconstriction was reported three decades ago. In particular, Donnerer and Lembeck 
described that capsaicin evokes a three-phase response in the rat. The second phase of 
this response was a vasoconstrictive response, which was found to be independent of 
sensory innervation (Donnerer and Lembeck 1982). Duckles even described the direct 
effect of capsaicin on vascular smooth muscle cells (Duckles 1986). The presence of 
TRPV1 in vascular tissue was further confirmed after the identification of its gene. 
Recently, functional TRPV1 expression in the smooth muscle cells of intrapulmonary 
arteries was related to pulmonary hypertension (Martin et al. 2012). Moreover, TRPV1 
staining in the smooth muscle layer of epineurial arteries together with a contractile 
response to capsaicin and resiniferatoxin was also noted previously (Davidson et al. 
2006). Our data confirm these earlier observations. In addition to the confirmation of 
earlier results, we were able to show that arteriolar TRPV1 expression is tightly regulated 
(arteries within a couple of micrometers show high or undetectable level of TRPV1 
expression) and that TRPV1 responses are suppressed in some cases, in spite of 
uniformly high TRPV1 expression.  
 These data provides evidence that TRPV1 represents an other significant vascular 
TRP channel. Our data suggest that TRPV1 is in its sensitized state in some skeletal 
muscle arteries (such as isolated from the gracilis muscle as presented here) and in the 
coronary arteries (Czikora et al. 2012), but it is inhibited in other blood vessels. It is also 
known, that TRPV1 stimulation has a divergent effects in vivo: it may evoke neurogenic 
vasodilation (for example in the skin) and it may also evoke vascular constrictions (in the 
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skeletal muscle) (Kark et al. 2008). These divergent effects suggest that systemic 
regulation of TRPV1 may be an effective tool to regulate blood distribution between 
tissues. Moreover, these divergent effects are in accordance with the 
immunohistochemical data presented here. It is expected that arteries with sensory 
neuronal innervation, but without vascular TRPV1 expression (such as blood vessels in 
the skin, Fig. 13) respond to TRPV1 stimulation by dilation. In contrast, arteries with 
high smooth muscle TRPV1 expression and without apparent sensory neuronal 
innervation (such as gracilis artery, Fig. 8) are expected to respond to the same TRPV1 
activation by constriction. An important addition to this hypothesis by this work is that it 
appears that TRPV1 expressed in the arteries is not necessarily functionally active. As a 
matter of fact, we have shown here that although TRPV1 is expressed in the large 
arteries, the activity of this receptor appears to be suppressed.   
 Taken together here we made an effort to investigate the functional expression of 
TRPV1 in the rat. It was found that TRPV1 expression in the vascular smooth muscle is 
regulated at the level of the individual blood vessels: some blood vessels showed 
intensive TRPV1 immunostaining, while nearby vessels were negative. Moreover, the 
activity of the smooth muscle expressed TRPV1 appeared to be suppressed in some 
cases. Nonetheless, TRPV1 was found to be widely expressed in the vasculature rat, 
suggesting a physiological role for these cation channels in vascular biology. 
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Tables 
Table 1 Details of the antibodies used in the study 
Specificity Region Developed in  Working dilution 
      Western blot Immunohistochemistry
TRPV1 C-terminal Rabbit 1:200 1:500 
TRPV1 N-terminal Rabbit 1:200 1:750 
TRPV1 3rd loop Rabbit 1:200 1:750 
TRPV1 3rd loop Rabbit N/A 1:100 
TRPV1 4th loop Rabbit 1:200 1:150 
TRPV1 N-term Rabbit 1:1000 1:500 
Smooth muscle 
actin   Mouse N/A 1:50 
Neurofilament   Mouse N/A 1:100 
anti rabbit-biotin   Goat N/A 1:200 
anti mouse-FITC   Goat N/A 1:200 
Streptavidin-Cy3   N/A N/A 1:500 
anti-rabbit-POD     1:40000 N/A 
 
 
 
 
 
 
 
 
 
 
Copyright © 2013 The Author(s) 
 
 at University of Debrecen on November 14, 2013jhc.sagepub.comDownloaded from 
JHC Express 
Accepted September 30, 2013 
This article can be cited as DOI: 10.1369/0022155413513589 
 
 
 
 
28 

Figure legends 
 
 
Figure 1 TRPV1 mRNA in peripheral tissues of the rat  
TRPV1 expression was tested as the mean of RT-PCR (A) and Q-PCR (B) in peripheral 
tissues of the rat. Isolated mRNA (0.5 μg) from various tissue sources (isolated arteries, 
veins, nerves, dorsal root ganglia and spinal cord) was subjected to RT-PCR and Q-PCR 
with a primer set specific to the rat TRPV1. Reaction mixtures were loaded on 2% 
agarose gels to separate PCR products. Bands at the apparent molecular size of 170 bp 
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were in accordance with the expected size of the product, while the band in the case of 
the isolated mesenteric artery was aspecific. Q-PCR experiments (B) revealed negligible 
expression of TRPV1 in mesenteric arteries (values were similar to those performed 
without template), but a reasonably high level of expression was found in other peripheral 
tissues (n=2-8, bars represent mean±SEM). 
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Figure 2 Specificity of TRPV1 antibodies  
Six commercially available anti TRPV1 antibodies were tested on dorsal root ganglia 
(cryostat sections) of the rat (red). Tissue sections were co-stained by a neurofilament 
specific antibody (green, neurons). Background staining was obtained by omitting the 
primary antibodies. Primary antibodies are indicated on the figure. Bars represent 100 
μm. Dilutions and details of the antibodies are summarized in Table 1. 
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Figure 3 Colocalization of TRPV1 and neurofilament immunoreactivities 
Dorsal root ganglia of the rat was stained by anti-TRPV1-N (A) and anti-TRPV1-C (B) 
antibodies (red channel) together with a neurofilament specific antibody (green channel) 
and a DAPI counter stain (blue channel). The merged images are also shown, besides to 
the separate channels. Bars represent 100 μm.  
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Figure 4 Specificity of neuronal TRPV1 staining 
Dorsal root ganglia of the rat was stained by anti-TRPV1-N (A and B) and anti-TRPV1-C 
(C and D) antibodies (red channel), together with a neurofilament (green channel) and 
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DNA (DAPI, blue channel) markers. Blocking peptides were synthesized according to 
the sequence of the immunogenic TRPV1 fragment to investigate the specificity of the 
TRPV1 staining. The positive staining disappeared when the antibodies were pre-
incubated with the blocking peptides (B and D). Bars represent 50 μm. 
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Figure 5 Specificity of TRPV1 antibodies in Western blotting 
Dorsal root ganglia (1) and carotid artery (2) was prepared from the rat. HEK293 (3) and 
HEK293 cells transfected by a GFP-TRPV1 encoding plasmid (4) were cultured in cell 
culture dishes. Samples were prepared in SDS sample buffer and loaded on 10% 
polyacrylamide gels (30 μg protein/well). Separated proteins were transferred onto 
nitrocellulose membranes and probed by antibodies developed against TRPV1. The 
dilutions were set as the product booklets suggested or at 1:50 (anti-TRPV1-N antibody). 
Membranes were incubated simultaneously with the secondary antibody (goat anti rabbit-
POD) and ECL was used for the detection. All of the membranes were developed 
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simultaneously in a Chemibis 3.2 imager. Exposure time was 6 min. Expected position of 
the endogenous TRPV1 is shown by empty arrows, filled arrows represent the position of 
the GFP-TRPV1.  
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Figure 6 TRPV1 expression in sensory neurons 
The selectivity of the anti-TRPV1-N (A and B) and anti-TRPV1-C (C and D) antibodies 
were tested in the dorsal root ganglia of the rat. Cryostat sections (10 μm) were stained by 
the TRPV1 antibodies (red), by a neurofilament (green, A and C) and a smooth muscle 
actin (green, B and D) specific antibody. DNA was labelled by DAPI (blue). Cross 
sectional area of the stained cells were calculated and plotted on histograms (anti-
TRPV1-N, panel E, anti-TRPV1-C, panel F). Evaluation was made by the ImageJ 
software. 
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Figure 7 Functional expression of TRPV1 in skeletal muscle blood vessels  
Cryostat sections were made from the gracilis muscle of the rat (10 μm) and were stained 
by anti-TRPV1-N (A and B) and anti-TRPV1-C (C and D) antibodies. TRPV1 (red) was 
co-stained by neurofilament (green, A and C) and smooth muscle specific actin (green, B 
and D) specific antibodies. The same arteries (indicated by the empty arrows) were 
isolated and mounted on an isobaric (cannulated) setup. Concentration-response to 
capsaicin (a TRPV1 specific agonist) and to norepinephrine are shown on the graph. 
Symbols represent the mean, error bars are S.E.M. of 5 independent determinations. 
Significant differences from the initial (before treatment) values are shown by asterisks. 
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Figure 8 TRPV1 expression in smooth muscle cells 
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The smooth muscle expression of TRPV1 was investigated in detail. Gracilis muscle 
tissue sections of the rat were probed with anti-TRPV1-N (A and B, red channels), anti-
TRPV1-C (C and D, red channels), anti-neurofilament (green channels) antibodies and 
with DAPI (blue channels). Merged images are also shown. In some cases the TRPV1 
specific antibodies were pre-absorbed by blocking peptides (preincubation with the 
blocking peptides, B and D). Note missing red staining in these cases, in particular on 
Panel A (colocalization of TRPV1 with the smooth muscle actin) versus Panel B 
(blocked TRPV1 binding, maintained smooth muscle actin staining). Bars represent 100 
μm. 
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Figure 9 Expression of TRPV1 in mesenteric blood vessels  
Cryostat sections were made from the mesenteric tissue (near the small intestines) of the 
rat (10 μm) and were stained by the anti-TRPV1-N (A and B) and anti-TRPV1-C (C and 
D)  antibodies to detect TRPV1 expression. TRPV1 (red) was co-stained by 
neurofilament (green, A and C) and smooth muscle specific actin (green, B and D) 
specific antibodies. Isolated arteries from the same tissue (third order arteries) were 
mounted on an isobaric vascular setup and the responses to capsaicin and to 
norepinephrine are shown on the graph (E). Symbols represent the mean, error bars are 
S.E.M. of 5 independent determinations. Significant difference from the initial value is 
shown by the asterisk. Bars represent 100 μm. 
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Figure 10 Expression of TRPV1 in the femoral artery  
Femoral artery tissue sections were probed by anti-TRPV1-N (red, A and B), anti-
TRPV1-C (red, C and D), neurofilament (green, A and C), smooth muscle actin (green, B 
and D) antibodies and with DAPI (blue channels). Arteries labelled by the empty arrows 
were mounted on an isometric contractile force measurement system. Responses to 
capsaicin (TRPV1 specific agonist) and to norepinephrine are shown on the graph (E). 
Symbols represent the mean, error bars are S.E.M. of 4 independent determinations. 
Asterisks represent significant constrictions. Bars represent 100 μm. 
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Figure 11 Expression of TRPV1 in the aorta  
The aorta of the rat was probed with probed by anti-TRPV1-N (red, Panels A and B), 
anti-TRPV1-C (red, C and D), neurofilament (green, A and C), smooth muscle actin 
(green, B and D) antibodies and with DAPI (blue channels). Contractions to capsaicin 
and norepinephrine were tested in an isometric contractile force measurement system. 
Results are shown on the graph (E). Symbols represent the mean, error bars are S.E.M. of 
6 independent determinations, asterisks show the significant constrictions over the initial 
values. Bars represent 100 μm. 
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Figure 12 Expression of TRPV1 in the carotid artery  
Cryostat sections were made from the carotid artery of the rat (10 μm) and were stained 
by the anti-TRPV1-N (A and B) and anti-TRPV1-C (C and D) antibodies to detect 
TRPV1 expression. TRPV1 (red) was co-stained by neurofilament (green, A and C) and 
smooth muscle specific actin (green, B and D) specific antibodies. The same arteries 
were isolated and mounted on an isometric (ring) setup. Concentration-responses to 
capsaicin and to U-46619 (a thromboxane A2 receptor agonist) are shown on the graph 
(E). Symbols represent the mean, error bars are S.E.M. of 8 independent determinations. 
Significant differences from the initial contractile force values are shown by the asterisks. 
Bars represent 100 μm. 
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Figure 13 Expression of TRPV1 in the skin 
Immunohistochemistry was performed in the skin at the hindpaw of the rat. Anti-TRPV1-
N (red, A and B), anti-TRPV1-C (red, C and D), neurofilament (green, A and C), smooth 
muscle actin (green, B and D) antibodies and with DAPI (blue channels). Colocalization 
of TRPV1 positive neurites with the neurofilament marker are shown in the inserts by 
higher magnification (bars within the inserts represent 10 μm). Bars in the lower 
magnification images represent 100 μm. 
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